Effect of nano-curcumin supplementation on angina status, and traditional and novel cardiovascular risk factors in overweight or obese patients with coronary slow flow phenomenon: a randomized double-blind placebo-controlled clinical trial.
Mahsa RezaeiMitra SoltaniElham AlipoorSeyed Mahdi RezayatAli Vasheghani-FarahaniMehdi YaseriAta FirouziMohammad-Javad Hosseinzadeh-AttarPublished in: BMC nutrition (2024)
This study was approved by the Ethics Committee of Tehran University of Medical Sciences (IR.TUMS.VCR.REC.1398.794). The study protocol was registered at Iranian Registry of Clinical Trials by IRCT20131125015536N8 registration ID at 19.06.2019.
Keyphrases
- clinical trial
- double blind
- placebo controlled
- cardiovascular risk factors
- study protocol
- obese patients
- phase ii
- phase iii
- bariatric surgery
- coronary artery disease
- coronary artery
- open label
- roux en y gastric bypass
- cardiovascular disease
- metabolic syndrome
- weight loss
- randomized controlled trial
- gastric bypass
- public health
- healthcare
- phase ii study
- physical activity
- heart failure
- squamous cell carcinoma
- big data
- atrial fibrillation
- left ventricular
- transcatheter aortic valve replacement
- locally advanced
- ejection fraction
- global health